Cargando…

Chemical Constitution, Pharmacological Effects and the Underlying Mechanism of Atractylenolides: A Review

Atractylenolides, comprising atractylenolide I, II, and III, represent the principal bioactive constituents of Atractylodes macrocephala, a traditional Chinese medicine. These compounds exhibit a diverse array of pharmacological properties, including anti-inflammatory, anti-cancer, and organ-protect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Zhiyi, Lin, Minqiu, He, Xinglishang, Dong, Yingjie, Chen, Yigong, Li, Bo, Chen, Suhong, Lv, Guiyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224166/ https://www.ncbi.nlm.nih.gov/pubmed/37241729 http://dx.doi.org/10.3390/molecules28103987

Ejemplares similares

The Mechanisms of Polysaccharides from Tonic Chinese Herbal Medicine on the Enhancement Immune Function: A Review
por: Xie, Zhiyi, et al.
Publicado: (2023)

Network Pharmacology Prediction and Pharmacological Verification Mechanism of Yeju Jiangya Decoction on Hypertension
por: Wang, Ting, et al.
Publicado: (2021)

UPLC-MS/MS of Atractylenolide I, Atractylenolide II, Atractylenolide III, and Atractyloside A in Rat Plasma after Oral Administration of Raw and Wheat Bran-Processed Atractylodis Rhizoma
por: Xu, Shizhao, et al.
Publicado: (2018)

Anti-tumor effects of Atractylenolide I on bladder cancer cells
por: Yu, Rui, et al.
Publicado: (2016)

Correction to: Anti-tumor effects of Atractylenolide I on bladder cancer cells
por: Yu, Rui, et al.
Publicado: (2018)

Dendrobium officinalis Six Nostrum Promotes Intestinal Urate Underexcretion via Regulations of Urate Transporter Proteins in Hyperuricemic Rats
por: Ge, Hongzhang, et al.
Publicado: (2023)

Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson’s Disease
por: More, Sandeep, et al.
Publicado: (2017)

Anti-Tumor Effects of Atractylenolide-I on Human Ovarian Cancer Cells
por: Long, Fangyi, et al.
Publicado: (2017)

Atractylenolide I inhibits antibiotic-induced dysbiosis of the intestinal microbiome
por: Liu, Penglin, et al.
Publicado: (2021)

A Randomized Pilot Study of Atractylenolide I on Gastric Cancer Cachexia Patients
por: Liu, Yi, et al.
Publicado: (2008)

ON THE RELATION OF INFLAMMATION TO THE CHEMICAL CONSTITUTION OF INJURIOUS AGENTS. ON THE PHARMACOLOGY OF INFLAMMATION
por: Opie, Eugene L.
Publicado: (1963)

Anti-Tumor Activity of Atractylenolide I in Human Colon Adenocarcinoma In Vitro
por: Chan, Ka Woon Karen, et al.
Publicado: (2020)

Polysaccharides of Dendrobium officinale Kimura & Migo Leaves Protect Against Ethanol-Induced Gastric Mucosal Injury via the AMPK/mTOR Signaling Pathway in Vitro and vivo
por: Ke, Yang, et al.
Publicado: (2020)

Corrigendum: Polysaccharides of Dendrobium officinale Kimura & Migo leaves protect against ethanol-induced gastric mucosal injury via the AMPK/mTOR signaling pathway in vitro and vivo
por: Ke, Yang, et al.
Publicado: (2022)

Atractylenolide III ameliorates spinal cord injury in rats by modulating microglial/macrophage polarization
por: Xue, Meng‐Tong, et al.
Publicado: (2022)

The Anticancer Effects of Atractylenolide III Associate With the Downregulation of Jak3/Stat3-Dependent IDO Expression
por: Liu, Jun-bao, et al.
Publicado: (2020)

Establishment of a mouse model of cancer cachexia with spleen deficiency syndrome and the effects of atractylenolide I
por: Zhang, Wan-li, et al.
Publicado: (2019)

Atractylenolide I alleviates ischemia/reperfusion injury by preserving mitochondrial function and inhibiting caspase-3 activity
por: Sun, Caiqin, et al.
Publicado: (2021)

Chemopreventive effects of atractylenolide II on mammary tumorigenesis via activating Nrf2-ARE pathway
por: Wang, Ting, et al.
Publicado: (2017)

Catalytic approach to in vivo metabolism of atractylenolide III using biomimetic iron–porphyrin complexes
por: Lim, Hanae, et al.
Publicado: (2021)

Atractylenolide III Attenuates Angiogenesis in Gastric Precancerous Lesions Through the Downregulation of Delta-Like Ligand 4
por: Gao, Ying, et al.
Publicado: (2022)

Applications of Network Pharmacology in Traditional Chinese Medicine Research
por: Zhou, Zhuchen, et al.
Publicado: (2020)

P2X7 receptor involved in antitumor activity of atractylenolide I in human cervical cancer cells
por: Han, Yue, et al.
Publicado: (2022)

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
por: Wang, Meng, et al.
Publicado: (2021)

Simultaneous Analysis of Hydrophobic Atractylenolides, Atractylon and Hydrophilic Sugars in Bai-Zhu Using a High-Performance Liquid Chromatography Column Tandem Technique
por: Gu, Zhixing, et al.
Publicado: (2023)

Preparative Purification of Linarin Extracts from Dendranthema indicum Flowers and Evaluation of Its Antihypertensive Effect
por: Qiaoshan, Yin, et al.
Publicado: (2014)

Tensile Mechanical Properties and Dynamic Constitutive Model of Polyurea Elastomer under Different Strain Rates
por: Chen, Yu, et al.
Publicado: (2022)

Atractylenolide III Ameliorates Bile Duct Ligation-Induced Liver Fibrosis by Inhibiting the PI3K/AKT Pathway and Regulating Glutamine Metabolism
por: Wang, Yan, et al.
Publicado: (2023)

Atractylenolide III ameliorated reflux esophagitis via PI3K/AKT/NF-κB/iNOS pathway in rats
por: Si, Xianzhe, et al.
Publicado: (2023)

The Chemical Constitution of Sex Hormones
por: Blackwood, J. H.
Publicado: (1935)

Anti-Tumor Effects of Atractylenolide I Isolated from Atractylodes macrocephala in Human Lung Carcinoma Cell Lines
por: Liu, Huanyi, et al.
Publicado: (2013)

Atractylenolide-III suppresses lipopolysaccharide-induced inflammation via downregulation of toll-like receptor 4 in mouse microglia
por: Novianti, Ela, et al.
Publicado: (2021)

Atractylenolide-1 alleviates gastroparesis in diabetic rats by activating the stem cell factor/c-kit signaling pathway
por: Li, Hui, et al.
Publicado: (2021)

Atractylenolide-I covalently binds to CYP11B2, selectively inhibits aldosterone synthesis, and improves hyperaldosteronism
por: Liu, Wenjuan, et al.
Publicado: (2022)

Atractylenolide III inhibits epithelial-mesenchymal transition in small intestine epithelial cells by activating the AMPK signaling pathway
por: Huang, Mingjin, et al.
Publicado: (2022)

Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL‐6 and tumour‐derived extracellular vesicles
por: Fan, Meng, et al.
Publicado: (2022)

Atractylenolide I inhibits EMT and enhances the antitumor effect of cabozantinib in prostate cancer via targeting Hsp27
por: Qiao, Pengfei, et al.
Publicado: (2023)

Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway
por: Li, Qian, et al.
Publicado: (2022)

Atractylenolide-I Protects Human SH-SY5Y Cells from 1-Methyl-4-Phenylpyridinium-Induced Apoptotic Cell Death
por: More, Sandeep Vasant, et al.
Publicado: (2017)

Miscellaneous Chemical Carcinogens: Chemical Constitution and Carcinogenic Activity
por: Badger, G. M.
Publicado: (1956)

Cannot write session to /tmp/vufind_sessions/sess_99s41s9im4bsb6jjmn5ltrgcjm